Inventor · disambiguated record
Daniel M. Canafax
Also filed as: CANAFAX DANIEL M
12 granted patents·10 pending applications·18 citations·filing 2004–2025
86Inventor score
Top patents by PatentIndex Score
22 records- 0195US11395801B2Modified release compositions of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2021·Granted Jul 26, 2022·9 cites·18 claims
- 0292US11510892B2Pharmacokinetics of combined release formulations of a γ-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2022·Granted Nov 29, 2022·2 cites·15 claims
- 0389US11304906B2Controlled release granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2021·Granted Apr 19, 2022·2 cites·16 claims
- 0488US11896573B2Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2021·Granted Feb 13, 2024·1 cites·11 claims
- 0588US11357734B2Pharmaceutical granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2021·Granted Jun 14, 2022·1 cites·18 claims
- 0685US12396956B2Modified release compositions of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2024·Granted Aug 26, 2025·0 cites·19 claims
- 0782US2025352481A1Modified release compositions of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2025·Application pending·0 cites
- 0880US2025352496A1Pharmaceutical compositions and oral dosage forms of ketamine derivativesXWPHARMA LTD·Filed 2025·Application pending·0 cites
- 0980US2024156772A1Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2024·Application pending·0 cites
- 1079US12396966B2Pharmaceutical compositions and oral dosage forms of ketamine derivativesXWPHARMA LTD·Filed 2023·Granted Aug 26, 2025·0 cites·23 claims
- 1179US11944597B2Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2022·Granted Apr 2, 2024·0 cites·22 claims
- 1278US11925710B2Modified release compositions of a GAMMA-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 1377US11690811B2Pharmaceutical compositions and oral dosage forms of ketamine derivativesXWPHARMA LTD·Filed 2022·Granted Jul 4, 2023·0 cites·8 claims
- 1476US2025041258A1Pharmaceutical compositions of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2024·Application pending·0 cites
- 1576US2025041425A1Excipient granulationsXWPHARMA LTD·Filed 2024·Application pending·0 cites
- 1674US2024130996A1Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2023·Application pending·0 cites
- 1773US12337066B2Controlled release granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2022·Granted Jun 24, 2025·0 cites·21 claims
- 1872US2025262157A1Controlled release granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2025·Application pending·0 cites
- 1968US2022323366A1Pharmaceutical granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2022·Application pending·0 cites
- 2062US8114909B2Treating or preventing restless legs syndrome using prodrugs of GABA analogsBARRETT RONALD W·Filed 2004·Granted Feb 14, 2012·3 cites·52 claims
- 2150US2009118365A1Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal PainXENOPORT INC·Filed 2008·Application pending·0 cites
- 2243US2011060040A1Uses of acyloxyalkyl carbamate prodrugs of tranexamic acidXENOPORT INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel M. Canafax files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →